Epstein & White Financial’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
$550K Buy
3,334
+46
+1% +$7.62K 0.15% 38
2021
Q1
$544K Sell
3,288
-251
-7% -$40.6K 0.16% 36
2020
Q4
$552K Sell
3,539
-447
-11% -$66K 0.17% 34
2020
Q3
$595K Sell
3,986
-370
-8% -$54.7K 0.21% 26
2020
Q2
$611K Sell
4,356
-2,330
-35% -$340K 0.23% 25
2020
Q1
$879K Sell
6,686
-2,026
-23% -$287K 0.37% 20
2019
Q4
$1.28M Sell
8,712
-237
-3% -$32.1K 0.56% 16
2019
Q3
$1.16M Buy
8,949
+2,839
+46% +$374K 0.57% 15
2019
Q2
$851K Buy
6,110
+3,548
+138% +$491K 0.45% 22
2019
Q1
$358K Sell
2,562
-253
-9% -$33.9K 0.21% 53
2018
Q4
$362K Buy
2,815
+228
+9% +$31.8K 0.23% 40
2018
Q3
$358K Sell
2,587
-131
-5% -$17.4K 0.24% 47
2018
Q2
$329K Sell
2,718
-139
-5% -$17.3K 0.24% 68
2018
Q1
$366K Buy
2,857
+357
+14% +$48.3K 0.23% 67
2017
Q4
$363K Buy
+2,500
New +$348K 0.21% 67

Other funds holding JNJ

Epstein & White Financial's JNJ Position: Q2 2021 in Review

Epstein & White Financial increased its Johnson & Johnson (JNJ) stake by 1.4% in Q2 2021, buying an estimated $7.62K and bringing the position to 3,334 shares worth $550K. The position accounts for 0.15% of the portfolio, ranked #38.

Epstein & White Financial first reported a position in JNJ in Q4 2017 and has held it in 15 quarters since. The position peaked at $1.28M in Q4 2019. 3,325 funds tracked by Wall St. Rank hold JNJ as of Q2 2021.

  • Epstein & White Financial held 3,334 shares of Johnson & Johnson worth $550K as of Q2 2021.
  • Epstein & White Financial bought 46 Johnson & Johnson shares in Q2 2021, an estimated $7.62K.
  • Johnson & Johnson made up 0.15% of Epstein & White Financial's portfolio in Q2 2021, its #38 holding.
  • Epstein & White Financial first reported a position in Johnson & Johnson in Q4 2017 and has held it in 15 quarters since.
  • Epstein & White Financial's Johnson & Johnson position peaked at $1.28M in Q4 2019.
  • 3,325 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2021.

Based on Epstein & White Financial's 13F filing for Q2 2021, filed 10 Aug 2021.